4.2 Article

Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Mortality Results from a Randomized Prostate-Cancer Screening Trial

Gerald L. Andriole et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Editorial Material Medicine, General & Internal

Pharmacogenetics-Tailoring Treatment for the Outliers

Janet Woodcock et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Editorial Material Pharmacology & Pharmacy

Warfarin and Pharmacogenomic Testing: What Would Pascal Do?

J. Russell Teagarden

PHARMACOTHERAPY (2009)

Article Pharmacology & Pharmacy

Couma-Gen: implications for future randomized trials of pharmacogenetic-based warfarin therapy

Lawrence J. Lesko et al.

PERSONALIZED MEDICINE (2008)

Article Biotechnology & Applied Microbiology

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Christine Lonjou et al.

PHARMACOGENETICS AND GENOMICS (2008)

Article Cardiac & Cardiovascular Systems

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

Jeffrey L. Anderson et al.

CIRCULATION (2007)

Article Allergy

HLA-B*1502-bound peptides: Implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome

Chih-Wen Ou Yang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)

Article Health Care Sciences & Services

Are randomized clinical trials good for us (in the short term)? Evidence for a trial effect

DA Braunholtz et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)